https://www.selleckchem.com/products/fgf401.html
4% vs 23.1%, P less then 0.001). PSM analysis further confirmed the clinical benefit of IMRT. In the matched cohort, radiation modality was independently correlated with OS and PFS. On multivariate analysis, smoking history (odds ratio [OR] 4.225, P = 0.002), primary tumor length (OR 2.764, P = 0.049), radiation modality (OR 10.760, P less then 0.001), planning target volume (OR 1.004, P less then 0.001), and lung V20 (OR 1.286, P = 0.002) were found to be significant predictors of RP. Conclusions Compared with 3DCRT, IMRT was associated
Like
Comment
Share
